U.S. Department of Health & Human Services
Email Updates Font Size Print Download Reader
The HHS regulations at 45 CFR 46.502 (e) require institutions or organizations to provide the approximate number of all active protocols and approximate number of active protocols conducted or supported by HHS when registering an IRB. For the purpose of these requirements, an “active protocol” is any protocol for which the IRB conducted an initial or a continuing review at a convened meeting or under an expedited review procedure during the preceding twelve months.
If the IRB reviews protocols regulated by both OHRP and the Food and Drug Administration (FDA), the institution or organization also must provide the approximate number of active protocols involving FDA-regulated products and a description of the types of FDA-regulated products (such as biological products, color additives, food additives, human drugs, or medical devices) involved in the protocols that the IRB reviews.
Last Reviewed: 12/02/2010